Baxter International Inc (NYSE:BAX)

58.96
Delayed Data
As of 3:59pm ET
 -0.75 / -1.26%
Today’s Change
57.49
Today|||52-Week Range
89.70
-31.31%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$29.5B

Company Description

Baxter International, Inc. engages in the provision of a portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies, premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software, and services. It operates through the following segment: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Contact Information

Baxter International, Inc.
One Baxter Parkway
Deerfield Illinois 60015-4625
P:(224) 948-2000
Investor Relations:
(224) 948-3020

Employees

Shareholders

Individual stakeholders6.58%
Mutual fund holders49.48%
Other institutional38.59%

Top Executives

Joe AlmeidaChairman, President & Chief Executive Officer
Giuseppe AccogliChief Operating Officer & Executive Vice President
James K. SaccaroChief Financial Officer & Executive Vice President
Paulo Henrique BolgarVice President-Research & Development
Tobi KarchmerChief Medical Officer & Senior Vice President